免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

ExSpiron 1Xi

K 號:K173181 · 2018-03-16

決定日期2018-03-16
產品代碼BZK
諮詢委員會AN
決定相當於

器材摘要

ExSpiron 1Xi is the device name listed in this FDA 510(k) record. The listed applicant is Respiratory Motion, Inc.. It received FDA 510(k) clearance on 2018-03-16 under 510(k) number K173181. The device is classified under product code BZK. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ExSpiron 1Xi?

ExSpiron 1Xi is a medical device that received FDA 510(k) clearance on 2018-03-16. The listed applicant is Respiratory Motion, Inc.. The 510(k) number is K173181.

When did ExSpiron 1Xi receive FDA 510(k) clearance?

ExSpiron 1Xi received FDA 510(k) clearance on 2018-03-16, under 510(k) number K173181.

Who is the listed applicant for ExSpiron 1Xi?

The FDA 510(k) record lists Respiratory Motion, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ExSpiron 1Xi?

The FDA product code for ExSpiron 1Xi is BZK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Respiratory Motion, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:BZK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑